Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 188

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia

Locher, Cosima, Frey Nascimento, Antje, Kirsch, Irving, Kossowsky, Joe, Meyer, Andrea, Gaab, Jens · 2017 · Pain

Abstract

Research on open-label placebos questions whether deception is a necessary characteristic of placebo effects. Yet, comparisons between open-label and deceptive placebos (DPs) are lacking. We therefore assessed effects of open-label placebos and DPs in comparison with no treatment (NT) with a standardized experimental heat pain paradigm in a randomized controlled trial in healthy participants. Participants (N = 160) were randomly assigned to NT, open-label placebo without rationale (OPR-), open-label placebo with rationale (OPR+), and DP. We conducted baseline and posttreatment measurements of heat pain threshold and tolerance. Apart from the NT, all groups received an application of a placebo cream. Primary outcomes were planned comparisons of heat pain tolerance and the corresponding intensity and unpleasantness ratings. Objective posttreatment pain tolerance did not differ among groups. However, for subjective heat pain ratings at the posttreatment tolerance level, groups with a rationale (OPR+ and DP) reported diminished heat pain intensity (t(146) = −2.15, P = 0.033, d = 0.43) and unpleasantness ratings (t(146) = −2.43, P = 0.016, d = 0.49) compared with the OPR-group. Interestingly, the OPR+ and the DP groups did not significantly differ in heat pain intensity (t(146) = −1.10, P = 0.272) or unpleasantness ratings (t(146) = −0.05, P = 0.961) at the posttreatment tolerance level. Our findings reveal that placebos with a plausible rationale are more effective than without a rationale. Even more, open-label placebos did not significantly differ in their effects from DPs. Therefore, we question the ubiquitously assumed necessity of concealment in placebo administration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/j.pain.0000000000001012

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 53

  1. Aulas, 2003, Efficacy of a non blind placebo prescription [in French], Encephale, 29, 68
  2. Barrett, 2006, Placebo, meaning, and health, Perspect Biol Med, 49, 178, 10.1353/pbm.2006.0019 · DOI
  3. Bergmann, 1994, A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain, Clin Trials Metaanal, 29, 41
  4. Blease, 2016, Are open-label placebos ethical? Informed consent and ethical equivocations, Bioethics, 30, 407, 10.1111/bioe.12245 · DOI
  5. Bystad, 2015, How can placebo effects best be applied in clinical practice? A narrative review, Psychol Res Behav Manag, 8, 41, 10.2147/PRBM.S75670 · DOI
  6. Carvalho, 2016, Open-label placebo treatment in chronic low back pain: a randomized controlled trial, PAIN, 157, 2766, 10.1097/j.pain.0000000000000700 · DOI · Paper page
  7. Charron, 2006, Direct comparison of placebo effects on clinical and experimental pain, Clin J Pain, 22, 204, 10.1097/01.ajp.0000161526.25374.e5 · DOI
  8. Colloca, 2005, Placebos and painkillers: is mind as real as matter?, Nat Rev Neurosci, 6, 545, 10.1038/nrn1705 · DOI · Paper page
  9. Colloca, 2016, Relieving pain using dose-extending placebos: a scoping review, PAIN, 157, 1590, 10.1097/j.pain.0000000000000566 · DOI
  10. Cragg, 2016, Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics, PAIN, 157, 530, 10.1097/j.pain.0000000000000431 · DOI
  11. Edwards, 2001, Ethnic differences in pain tolerance: clinical implications in a chronic pain population, Psychosom Med, 63, 316, 10.1097/00006842-200103000-00018 · DOI · Paper page
  12. Fässler, 2011, Placebo interventions in practice: a questionnaire survey on the attitudes of patients and physicians, Br J Gen Pract, 61, 101, 10.3399/bjgp11X556209 · DOI
  13. Foddy, 2009, A duty to deceive: placebos in clinical practice, Am J Bioeth, 9, 4, 10.1080/15265160903318350 · DOI
  14. Forsberg, 2017, The placebo analgesic effect in healthy individuals and patients: a meta-analysis, Psychosom Med, 79, 388, 10.1097/PSY.0000000000000432 · DOI
  15. Gaab, 2016, Go open: a plea for transparency in psychotherapy, Psychol Conscious (Wash D C), 3, 175
  16. Gaab, 2017, Psychosocial stress-induced analgesia: an examination of effects on heat pain threshold and tolerance and of neuroendocrine mediation, Neuropsychobiology, 74, 87, 10.1159/000454986 · DOI
  17. Geers, 2005, Goal activation, expectations, and the placebo effect, J Pers Soc Psychol, 89, 143, 10.1037/0022-3514.89.2.143 · DOI · Paper page
  18. Goetz, 2008, Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions, Mov Disord, 23, 690, 10.1002/mds.21894 · DOI · Paper page
  19. Granot, 2003, Psychophysics of phasic and tonic heat pain stimuli by quantitative sensory testing in healthy subjects, Eur J Pain, 7, 139, 10.1016/S1090-3801(02)00087-3 · DOI
  20. Harris, 1983, The validity of experimental pain measures, PAIN, 17, 369, 10.1016/0304-3959(83)90168-9 · DOI
  21. Hróbjartsson, 2001, Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment, N Engl J Med, 344, 1594, 10.1056/NEJM200105243442106 · DOI · Paper page
  22. Kaptchuk, 2015, Placebo effects in medicine, N Engl J Med, 373, 8, 10.1056/NEJMp1504023 · DOI · Paper page
  23. Kelley, 2012, Open-label placebo for major depressive disorder: a pilot randomized controlled trial, Psychother Psychosom, 81, 312, 10.1159/000337053 · DOI · Paper page
  24. Krummenacher, 2014, Expectancy-induced placebo analgesia in children and the role of magical thinking, J Pain, 15, 1282, 10.1016/j.jpain.2014.09.005 · DOI
  25. Kut, 2007, Changes in self-perceived role identity modulate pain perception, PAIN, 131, 191, 10.1016/j.pain.2007.04.012 · DOI
  26. Macedo, 2008, Placebo response in the prophylaxis of migraine: a meta-analysis, Eur J Pain, 12, 68, 10.1016/j.ejpain.2007.03.002 · DOI
  27. Maeoka, 2015, The influence of repeated pain stimulation on the emotional aspect of pain: a preliminary study in healthy volunteers, J Pain Res, 8, 431, 10.2147/JPR.S86732 · DOI
  28. Martin, 2010, Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain, PAIN, 149, 208, 10.1016/j.pain.2009.12.004 · DOI
  29. McCambridge, 2014, Patient preferences and performance bias in a weight loss trial with a usual care arm, Patient Educ Couns, 95, 243, 10.1016/j.pec.2014.01.003 · DOI
  30. Miller, 2005, Deception in research on the placebo effect, PLoS Med, 2, e262, 10.1371/journal.pmed.0020262 · DOI · Paper page
  31. Moerman, 2002, Deconstructing the placebo effect and finding the meaning response, Ann Intern Med, 136, 471, 10.7326/0003-4819-136-6-200203190-00011 · DOI · Paper page
  32. Oldfield, 1971, The assessment and analysis of handedness: the Edinburgh inventory, Neuropsychologia, 9, 97, 10.1016/0028-3932(71)90067-4 · DOI · Paper page
  33. Park, 1965, Nonblind placebo trial: an exploration of neurotic patients' responses to placebo when its inert content is disclosed, Arch Gen Psychiatry, 12, 36, 10.1001/archpsyc.1965.01720340008002 · DOI
  34. Perlis, 2015, Durability of treatment response to zolpidem with three different maintenance regimens: a preliminary study, Sleep Med, 16, 1160, 10.1016/j.sleep.2015.06.015 · DOI
  35. Petersen, 2014, Expectations and positive emotional feelings accompany reductions in ongoing and evoked neuropathic pain following placebo interventions, PAIN, 155, 2687, 10.1016/j.pain.2014.09.036 · DOI
  36. Petersen, 2012, Placebo manipulations reduce hyperalgesia in neuropathic pain, PAIN, 153, 1292, 10.1016/j.pain.2012.03.011 · DOI
  37. Petkovic, 2015, Effects of placebos without deception compared with no treatment: protocol for a systematic review and meta-analysis, BMJ Open, 5, e009428, 10.1136/bmjopen-2015-009428 · DOI
  38. Price, 1999, An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm, PAIN, 83, 147, 10.1016/S0304-3959(99)00081-0 · DOI · Paper page
  39. Quinn, 2017, Latent inhibition reduces nocebo nausea, even without deception, Ann Behav Med, 51, 432, 10.1007/s12160-016-9867-8 · DOI
  40. Rief, 2012, The hidden effects of blinded, placebo-controlled randomized trials: an experimental investigation, PAIN, 153, 2473, 10.1016/j.pain.2012.09.007 · DOI
  41. Rosenthal, 1964, Experimenter outcome-orientation and the results of the psychological experiment, Psychol Bull, 61, 405, 10.1037/h0045850 · DOI
  42. Ruxton, 2008, Time for some a priori thinking about post hoc testing, Behav Ecol, 19, 690, 10.1093/beheco/arn020 · DOI · Paper page
  43. Sandler, 2008, Open-label use of placebos in the treatment of ADHD: a pilot study, Child Care Health Dev, 34, 104, 10.1111/j.1365-2214.2007.00797.x · DOI
  44. Sandler, 2010, Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder?, J Dev Behav Pediatr, 31, 369, 10.1097/DBP.0b013e3181e121ed · DOI
  45. Schaefer, 2016, Open-label placebos improve symptoms in allergic rhinitis: a randomized controlled trial, Psychother Psychosom, 85, 373, 10.1159/000447242 · DOI
  46. Schwarz, 2015, Cognition and the placebo effect–dissociating subjective perception and actual performance, PLoS One, 10, e0130492, 10.1371/journal.pone.0130492 · DOI
  47. Skingley, 2014, Experiences of being a control group: lessons from a UK-based randomized controlled trial of group singing as a health promotion initiative for older people, Health Promot Int, 29, 751, 10.1093/heapro/dat026 · DOI
  48. Starrels, 2011, Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain, J Gen Intern Med, 26, 958, 10.1007/s11606-011-1648-2 · DOI
  49. Turi, 2017, Placebo intervention enhances reward learning in healthy individuals, Sci Rep, 7, 41028, 10.1038/srep41028 · DOI
  50. Tuttle, 2015, Increasing placebo responses over time in U.S. clinical trials of neuropathic pain, PAIN, 156, 2616, 10.1097/j.pain.0000000000000333 · DOI · Paper page
  51. Vase, 2009, Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007, PAIN, 145, 36, 10.1016/j.pain.2009.04.008 · DOI · Paper page
  52. Wampold, 2005, The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials, J Clin Psychol, 61, 835, 10.1002/jclp.20129 · DOI · Paper page
  53. Wechsler, 2011, Active albuterol or placebo, sham acupuncture, or no intervention in asthma, N Engl J Med, 365, 119, 10.1056/NEJMoa1103319 · DOI · Paper page

Cited by

See all 188

Metadata

Authors
Locher, C., Frey Nascimento, A., Kirsch, I., Kossowsky, J., Meyer, A., & Gaab, J.
Venue
Pain
Published
2017-07-12
Volume
158
Issue
12
Pages
2320-2328
ISSN
  • 0304-3959 (ISSN-L)
  • 1872-6623
OpenAlex
W2736229323
Cited by
188
References
16
FWCI
9.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. https://app.cochat.ai/papers/10.1097/j.pain.0000000000001012
The paper
Locher, C., Frey Nascimento, A., Kirsch, I., Kossowsky, J., Meyer, A., & Gaab, J. (2017). Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain. https://doi.org/10.1097/j.pain.0000000000001012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.